Pomdoctor Ltd
Research Pomdoctor Ltd (POM) on Bullrun: market cap USD 91.20M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPOM
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyUSD
- Market capUSD 91.20M
- Financial periodFY2025
- RevenueCNY 399.91M
- Revenue growth16.7%
- Net income-CNY 212.58M
- Free cash flow-CNY 149.49M
- Gross margin13.1%
Valuation Snapshot
latest market cap is USD 91.20M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 399.91M | -CNY 212.58M | -CNY 149.49M | 13.1% | -3.66 | CNY 9.58M | CNY 454.94M | -CNY 453.97M |
| FY2024 | CNY 342.56M | -CNY 143.36M | -CNY 16.17M | 13.9% | -21.79 | CNY 7.65M | CNY 441.10M | -CNY 2.26B |
| FY2023 | CNY 304.85M | -CNY 145.39M | -CNY 45.91M | 12.7% | -22.1 | CNY 6.72M | CNY 413.29M | -CNY 2.12B |
| FY2022 | CNY 245.22M | -CNY 125.51M | -CNY 22.02M | 22.4% | -19.07 | CNY 2.49M | CNY 361.24M | -CNY 1.97B |
| FY2021 | CNY 215.38M | -CNY 188.40M | -CNY 15.68M | 24.4% | -1.59 | CNY 2.17M | CNY 341.26M | -CNY 1.85B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 91.20M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 34.35M | n/a | n/a | n/a |
About Pomdoctor Ltd
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Pomdoctor Ltd's market cap?
Pomdoctor Ltd's market capitalization is USD 91.20M.
What does Pomdoctor Ltd do?
Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants.